1. Home
  2. TLS vs ALDX Comparison

TLS vs ALDX Comparison

Compare TLS & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telos Corporation

TLS

Telos Corporation

HOLD

Current Price

$4.30

Market Cap

303.9M

Sector

Technology

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$4.78

Market Cap

317.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLS
ALDX
Founded
1969
2004
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
303.9M
317.7M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
TLS
ALDX
Price
$4.30
$4.78
Analyst Decision
Buy
Strong Buy
Analyst Count
5
2
Target Price
$7.75
$9.50
AVG Volume (30 Days)
715.4K
827.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
40.43
EPS
N/A
N/A
Revenue
$108,272,000.00
N/A
Revenue This Year
$52.26
N/A
Revenue Next Year
$19.65
$123.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.83
$1.18
52 Week High
$8.36
$7.19

Technical Indicators

Market Signals
Indicator
TLS
ALDX
Relative Strength Index (RSI) 44.23 42.44
Support Level $3.82 $4.74
Resistance Level $5.95 $5.70
Average True Range (ATR) 0.26 0.33
MACD 0.07 -0.07
Stochastic Oscillator 51.65 30.55

Price Performance

Historical Comparison
TLS
ALDX

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: